The Kidney Project: How UCSF's Implantable Artificial Kidney Works

Facebook ↗WhatsApp ↗

First published May 11, 2020.

The Kidney Project's Bioartificial Device Reached a Preclinical Milestone

The Kidney Project at the University of California, San Francisco (UCSF) is developing an implantable bioartificial kidney: a device about the size of a smartphone, meant to sit inside the body and do the main work of a failing kidney without dialysis or a donor organ. It is not available to patients. As of the latest public reports, its parts have been tested in animals, and the complete device has not yet been through human trials.

The milestone that put the project in the news came in November 2019, when the team reported that living human kidney cells, housed inside a small bioreactor, had been implanted in large animals and stayed healthy without any drugs to suppress the immune system. Here is how the device is meant to work, what that experiment showed, what has happened since, and what people living with kidney failure can realistically expect.

Why an implantable kidney matters

Healthy kidneys filter the blood all day, removing waste and excess fluid, balancing salts and helping control blood pressure. When they fail, there are two established treatments: dialysis, which does part of that filtering with a machine or through the lining of the abdomen, and a kidney transplant.

Both have serious limits. Hemodialysis typically means sessions of around four hours, three times a week, and people on long-term dialysis face high rates of complications. Transplants work best, but there are far fewer donor kidneys than people who need them. In the United States alone, more than 80 percent of the roughly 100,000 people on the national organ waiting list need a kidney, while about 25,000 kidney transplants were performed in 2021; many patients wait several years, and some die waiting. Worldwide, millions of people need dialysis or a transplant, and in many countries most of them cannot get either.

An implanted device that did a kidney’s job without a donor, and without lifelong anti-rejection drugs, would change that picture. That is the goal the Kidney Project has set itself.

How the bioartificial kidney is designed

The project is co-led by bioengineer Shuvo Roy at UCSF and nephrologist William Fissell at Vanderbilt University. Their design has two parts that copy the two main jobs of a natural kidney.

The hemofilter

The first part is a filter built from silicon membranes containing precisely shaped nanoscale pores, produced with the same techniques used to make computer chips. Blood flows past the membranes, and the pores let water, salts and small waste molecules through while holding back blood cells and larger proteins. The finished device is meant to be driven by the body’s own blood pressure, with no batteries or external power supply.

The bioreactor

Filtering alone is not enough. A natural kidney also reabsorbs water and useful substances, and performs metabolic and hormonal work. The second part of the device is a bioreactor containing cultured human kidney cells, held on a scaffold and shielded behind the same kind of silicon membrane. The membrane is meant to let nutrients and signals pass while keeping the patient’s immune cells away from the transplanted cells, which is why the team hopes no immunosuppressant drugs will be needed.

What the 2019 animal experiment showed

In the experiment announced in November 2019, the researchers implanted the bioreactor component, loaded with human kidney cells, into large animals. The cells survived and kept working, and the animals did not mount a damaging immune reaction, even though they were not given immunosuppressants.

Shuvo Roy described it as “the first demonstration that kidney cells can be implanted successfully without immunosuppression”. He also stressed that the next steps would be hard: scaling the bioreactor up, combining it with the filter, and producing living cells in carefully controlled manufacturing facilities.

It is worth being precise about what this was. It was a test of one component, in animals, over a limited period. It showed that a key piece of the design could work, not that a finished artificial kidney exists. Earlier reports that described it as a working replacement kidney went further than the evidence.

Progress since 2019

The project has continued to move forward, step by step. In September 2021, the team won a $650,000 KidneyX prize, a competition run by the US Department of Health and Human Services and the American Society of Nephrology, for showing that a prototype combining the filter and the bioreactor could work in a preclinical setting without immune-suppressing drugs or blood thinners.

In June 2023 it received a further $1 million KidneyX award to scale the device up toward full human size. The team has also described a simpler first product called iHemo, an implantable dialysis device based on the filter alone, which it hopes to take into a first human trial once it has been shown to work in pig models of kidney failure.

The full bioartificial kidney still needs larger and longer animal studies, manufacturing that meets medical standards, and clearance from regulators such as the US Food and Drug Administration before human trials can begin. The team itself has described the complete device as still some years from clinical use.

Other routes to replacing a kidney

The Kidney Project is not the only effort to tackle the donor shortage. Several groups are working on wearable or portable dialysis machines that would free patients from clinic sessions. Researchers are also growing kidney tissue from stem cells, known as organoids, although these are still far from a full working organ.

The most dramatic recent progress has come from xenotransplantation, the use of organs from genetically modified pigs. In 2021 surgeons temporarily attached a pig kidney to a brain-dead human, and from 2024 a small number of living patients in the United States received gene-edited pig kidneys in experimental procedures. These are early, closely monitored cases, and their long-term results are still being studied.

What this means for patients today

For anyone living with chronic kidney disease or kidney failure, the honest message is one of cautious hope. Engineering advances like the Kidney Project’s are real, and they could one day give people an alternative to dialysis and long transplant waits. They are not treatments you can sign up for today, and online claims that an artificial kidney has already ended the need for dialysis are not accurate.

Today, dialysis and transplantation remain the treatments for kidney failure, and much can be done earlier on to slow kidney disease. Anyone with questions about their own kidney health, or about joining a clinical trial, should talk to their doctor or kidney care team, who can explain which options fit their situation. Reliable background is available from the US National Institute of Diabetes and Digestive and Kidney Diseases.

Sources: UCSF School of Pharmacy: Implantable bioartificial kidney achieves preclinical milestone (2019); Smithsonian Magazine on the 2021 KidneyX prize; UCSF: Scaling the bioartificial kidney (2023); UCSF: The Kidney Project; University of California: The Kidney Project tests a prototype bioartificial kidney (2021); Help Hope Live: transplant waiting list figures; NIDDK: Kidney disease; Wikipedia: Xenotransplantation.

COMMENTS